Khan, Sadiya S.

Risk-based primary prevention of heart failure: a scientific statement from the American Heart Association

Khan, S. S., Breathett, K., Braun, L. T., Chow, S. L., Gupta, D. K., Lekavich, C., Lloyd-Jones, D. M., Ndumele, C. E., Rodriguez, C. J., Allen, L. A., et al. (2025) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 75

Discontinuation of glucagon-like peptide-1 receptor agonists.

Khan, S. S., Ndumele, C. E., & Kazi, D. S. (2025) · JAMA

Diabetes Treatment and ManagementMedication Adherence and Compliance

Cited by 60

Semaglutide Eligibility Across All Current Indications for US Adults

Shi, I., Khan, S. S., Yeh, R. W., Ho, J. E., Dahabreh, I. J., & Kazi, D. S. (2025) · JAMA Cardiology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 53

Heterogeneity in Obesity Prevalence Among Asian American Adults

Shah, N. S., Luncheon, C., Kandula, N. R., Khan, S. S., Pan, L., Gillespie, C., Loustalot, F., & Fang, J. (2022) · Annals of Internal Medicine

Obesity, Physical Activity, DietDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 51

Proportional Mortality From Ischemic Heart Disease Among Asian American Subgroups, From 2018 to 2020

Shah, N. S., Palaniappan, L. P., & Khan, S. S. (2022) · JAMA Internal Medicine

Healthcare Systems and Public HealthHealth disparities and outcomes

Cited by 23

Pragmatic Approaches to the Evaluation and Monitoring of Artificial Intelligence in Health Care: A Science Advisory From the American Heart Association

Jain, S. S., Goto, S., Hall, J. L., Khan, S. S., MacRae, C. A., Ofori, C., Pegus, C., Pencina, M., Peterson, E. D., Schwamm, L. H., et al. (2025) · Circulation

Artificial Intelligence in Healthcare and EducationEthics and Social Impacts of AI

Cited by 23

Improving postpartum and long-term health after an adverse pregnancy outcome: examining interventions from a health equity perspective

DITOSTO, J. D., ROYTMAN, M. V., DOLAN, B. M., KHAN, S. S., NIZNIK, C. M., & YEE, L. M. (2023) · Clinical Obstetrics & Gynecology

Gestational Diabetes Research and ManagementPregnancy and preeclampsia studies

Cited by 21

Prevalence of Cardiovascular‐Kidney‐Metabolic Stages in US Adolescents and Relationship to Social Determinants of Health

Baker‐Smith, C. M., Gauen, A. M., Petito, L. C., Khan, S. S., & Allen, N. B. (2025) · Journal of the American Heart Association

Cardiovascular Health and Risk FactorsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 18

Use of risk assessment to guide decision-making for blood pressure management in the primary prevention of cardiovascular disease: a scientific statement from the American Heart Association and American College of Cardiology

Khan, S. S., Lloyd-Jones, D. M., Abdalla, M., Bello, N. A., Blyler, C. A., Carter, J., Commodore-Mensah, Y., Ferdinand, K. C., Johnson, H. M., Jones, D., et al. (2025) · JACC

Blood Pressure and Hypertension StudiesClinical practice guidelines implementation

Cited by 16

Hypertension-Related Cardiovascular Mortality in Asian American Subgroups

Shah, N. S., Shimbo, D., Muntner, P., Huffman, M. D., Kandula, N. R., Mefford, M. T., Lloyd-Jones, D. M., & Khan, S. S. (2023) · American Journal of Preventive Medicine

Blood Pressure and Hypertension StudiesHealthcare Systems and Public Health

Cited by 13

Predicted Risk, Preclinical Heart Failure Measures, and Incident Heart Failure

Grant, J. K., Zhang, S., Khan, S. S., Ozkan, B., Blumer, V., Nambi, V., Echouffo-Tcheugui, J. B., Pandey, A., Blumenthal, R. S., Ballantyne, C. M., et al. (2025) · JACC: Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 8

Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know?

Abdul Jabbar, A. B., Inam, M., Butt, N., Khan, S. S., Sheikh, S., Khoja, A., Perry, B., Gomez, G. Z., Slipczuk, L., & Virani, S. S. (2025) · Current Atherosclerosis Reports

Health Promotion and Cardiovascular PreventionLipoproteins and Cardiovascular Health

Cited by 7

Abstract 4145988: Individual- and Community-level Socioeconomic Differences in Use of GLP-1 Receptor Agonists in Diabetes

Chaudhary, R., Decker, S., Song, Y., Khan, S., Ndumele, C., & Kazi, D. (2024) · Circulation

Diabetes Treatment and ManagementHealth disparities and outcomes

Cited by 0